The company is founded in 2017 by Jimmy Bak as a spin-off from the Technical University of Denmark (DTU).
In the following years the company have been busy with development of prototypes of UVC light source and UVC light-guide. This has been followed by proof of concept and a 6-log unit reduction of selected pathogens inside endotracheal tubes and CVC extension line tube part (in vitro).
In 2021 Rolf H. Sprunk-Jansen takes over the majority of the shares and becomes Chief Executive Officer focusing on making a world-class medical device together with founder Jimmy Bak.
Chief Executive Officer
Responsible for general management, commercial & strategic development. Rolf, M.Sc. Business, is a well-rounded business executive with extensive international experience within commercial development of high-tech products and technology companies.
Previous, Rolf co-founded and lead the high-tech company LED iBond from its transition from start-up to a listed company on NASDAQ First North. He still remains one of main shareowner of the company.
Mobile +45 2020 3005
Email: rsj (at) uvclinical.com
CTO & Founder
Founder, responsible for technology and IPR since 2017 and has worked with this technology since 2009.
Jimmy has a M. Sc. in chemistry and physics and a Master degree in applied statistics. Background in spectroscopy and optics at Risø National Lab and DTU (Technical University of Denmark).
With his strong and broad academic background, Jimmy has started the scientific work with UV-C LED disinfection in the clinical area. He has published several scientific papers.
Chairman of the Board of Directors
Skilled C-level executive and board member in high tech start up companies, especially within automation, clean tech and medical device.
Degrees in Chemical Engineering (DTU) and International Trade (CBS).
Selected key roles:
CEO, SDI – SDI invests in innovative early stage tech-based companies within Industry, Cleantech, IKT & Big Data and Medical Device. SDI holds ownership positions in 28 companies.
Chairman of the Board, FOM Technologies. FOM Specializes in machines and equipment for slot-die coating of functional materials. FOM Technologies was the most successful IPO at Nasdaq First North in 2020. In 2021, FESE selected FOM Technologies the best European IPO in the Rising Star Category.
Board member, Vulcur Medtech. Vulcur Medtech is developing FlashHeal, a medical device for painless treatment for chronic wounds to help prevent amputations among diabetic patients and other chronic wound patients.
Member of the Board of Directors
Claus holds a M.Sc. in Strategy and Management, and a Diploma in Finance from Copenhagen Business School. Additionally, Claus has conducted studies at various universities in France and US.
Claus has 20+ years of C-level experience, including a position as partner and strategic advisor at Qvartz (now Bain&Co), a position as CEO for ECCO Sko Northern Europe and a position as CFO/CCO for Oncology Venture A/S. Further, Claus has held numerous board member positions in various industries over the last 8 years (Retail, Biotech, Automotive and Technical installation services).
Claus’ experience includes strategic development and transformations of companies, SME’s as well as large global companies. Claus has been actively involved in listing companies, raising +300 mDKK in equity from capital markets and also driving cross-border M&A activities of listed companies.
Member of the Board of Directors
Carsten has held senior positions in the financial sector and Deloitte for more than 20 years. He has a master of laws from the University of Copenhagen and a banking degree from Danske Bank.
Carsten has experience as a board member and co-owner of several small and medium-sized companies. As an external consultant, he has worked as strategy consultant in a number of small and medium-sized companies.
Chief Executive Officer & Member of the Board of Directors